NCT04225117 2025-11-03A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)Astellas Pharma IncPhase 2 Active not recruiting329 enrolled
NCT04223856 2025-06-13EV-302Astellas Pharma IncPhase 3 Active not recruiting886 enrolled 12 charts 1 FDA